These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 25938424)

  • 1. Exploring the synthesis and anticancer potential of L-tyrosine-platinum(II) hybrid molecules.
    Descôteaux C; Brasseur K; Leblanc V; Asselin E; Bérubé G
    Med Chem; 2015; 11(8):717-24. PubMed ID: 25938424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Second-generation testosterone-platinum(II) hybrids for site-specific treatment of androgen receptor positive prostate cancer: Design, synthesis and antiproliferative activity.
    Ouellette V; Côté MF; Gaudreault RC; Tajmir-Riahi HA; Bérubé G
    Eur J Med Chem; 2019 Oct; 179():660-666. PubMed ID: 31279298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, characterization and biological investigation of platinum(ii) complexes with asparagusic acid derivatives as ligands.
    Hildebrandt J; Trautwein R; Kritsch D; Häfner N; Görls H; Dürst M; Runnebaum IB; Weigand W
    Dalton Trans; 2019 Jan; 48(3):936-944. PubMed ID: 30565617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of geometric isomerism on the anticancer activity of the monofunctional platinum complex trans-[Pt(NH
    Zhou W; Almeqdadi M; Xifaras ME; Riddell IA; Yilmaz ÖH; Lippard SJ
    Chem Commun (Camb); 2018 Mar; 54(22):2788-2791. PubMed ID: 29484327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morpholine or methylpiperazine and salicylaldimine based heteroleptic square planner platinum (II) complexes: In vitro anticancer study and growth retardation effect on E. coli.
    Rahman FU; Ali A; Khan IU; Duong HQ; Yu SB; Lin YJ; Wang H; Li ZT; Zhang DW
    Eur J Med Chem; 2017 May; 131():263-274. PubMed ID: 28334655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monofunctional platinum(ii) anticancer complexes based on multidentate phenanthridine-containing ligand frameworks.
    Lozada IB; Huang B; Stilgenbauer M; Beach T; Qiu Z; Zheng Y; Herbert DE
    Dalton Trans; 2020 May; 49(20):6557-6560. PubMed ID: 32342084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved synthesis of unique estradiol-linked platinum(II) complexes showing potent cytocidal activity and affinity for the estrogen receptor alpha and beta.
    Descôteaux C; Leblanc V; Bélanger G; Parent S; Asselin E; Bérubé G
    Steroids; 2008 Oct; 73(11):1077-89. PubMed ID: 18572212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel Antitumor Platinum(II) Conjugates Containing the Nonsteroidal Anti-inflammatory Agent Diclofenac: Synthesis and Dual Mechanisms of Antiproliferative Effects.
    Intini FP; Zajac J; Novohradsky V; Saltarella T; Pacifico C; Brabec V; Natile G; Kasparkova J
    Inorg Chem; 2017 Feb; 56(3):1483-1497. PubMed ID: 28102676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and in vitro characterization of platinum(II) anticancer coordinates using FTIR spectroscopy and NCI COMPARE: A fast method for new compound discovery.
    Berger G; Leclercqz H; Derenne A; Gelbcke M; Goormaghtigh E; Nève J; Mathieu V; Dufrasne F
    Bioorg Med Chem; 2014 Jul; 22(13):3527-36. PubMed ID: 24818960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quinoxaline-2-carboxamide as a carrier ligand in two new platinum(II) compounds: Synthesis, crystal structure, cytotoxic activity and DNA interaction.
    Marqués-Gallego P; Gamiz-Gonzalez MA; Fortea-Pérez FR; Lutz M; Spek AL; Pevec A; Kozlevčar B; Reedijk J
    Dalton Trans; 2010 Jun; 39(21):5152-8. PubMed ID: 20419195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toward overcoming cisplatin resistance via sterically hindered platinum(II) complexes.
    Yu H; Gou S; Wang Z; Chen F; Fang L
    Eur J Med Chem; 2016 May; 114():141-52. PubMed ID: 26974381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and evaluation of series of diazine-bridged dinuclear platinum(II) complexes through in vitro toxicity and molecular modeling: correlation between structure and activity of Pt(II) complexes.
    Senerovic L; Zivkovic MD; Veselinovic A; Pavic A; Djuran MI; Rajkovic S; Nikodinovic-Runic J
    J Med Chem; 2015 Feb; 58(3):1442-51. PubMed ID: 25551180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chlorambucil-conjugated platinum(IV) prodrugs to treat triple-negative breast cancer in vitro and in vivo.
    Ma ZY; Wang DB; Song XQ; Wu YG; Chen Q; Zhao CL; Li JY; Cheng SH; Xu JY
    Eur J Med Chem; 2018 Sep; 157():1292-1299. PubMed ID: 30195239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EGFR-targeting peptide-coupled platinum(IV) complexes.
    Mayr J; Hager S; Koblmüller B; Klose MHM; Holste K; Fischer B; Pelivan K; Berger W; Heffeter P; Kowol CR; Keppler BK
    J Biol Inorg Chem; 2017 Jun; 22(4):591-603. PubMed ID: 28405842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. On the stability and biological behavior of cyclometallated Pt(IV) complexes with halido and aryl ligands in the axial positions.
    Escolà A; Crespo M; López C; Quirante J; Jayaraman A; Polat IH; Badía J; Baldomà L; Cascante M
    Bioorg Med Chem; 2016 Nov; 24(22):5804-5815. PubMed ID: 27670096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Drug discovery research in in-vivo antitumor-active azolato-bridged dinuclear Pt(II) complexes].
    Komeda S
    Yakugaku Zasshi; 2012; 132(3):253-9. PubMed ID: 22382827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coordination-driven self-assembly of a Pt(iv) prodrug-conjugated supramolecular hexagon.
    Yue Z; Wang H; Li Y; Qin Y; Xu L; Bowers DJ; Gangoda M; Li X; Yang HB; Zheng YR
    Chem Commun (Camb); 2018 Jan; 54(7):731-734. PubMed ID: 29303526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel series of pyrazole-platinum(II) complexes as potential anti-cancer agents that induce cell cycle arrest and apoptosis in breast cancer cells.
    Czarnomysy R; Surażyński A; Muszynska A; Gornowicz A; Bielawska A; Bielawski K
    J Enzyme Inhib Med Chem; 2018 Dec; 33(1):1006-1023. PubMed ID: 29862867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, spectroscopic and biological studies of a fluorescent Pt(II) (terpy) based 1,8-naphthalimide conjugate as a DNA targeting agent.
    Banerjee S; Kitchen JA; Bright SA; O'Brien JE; Williams DC; Kelly JM; Gunnlaugsson T
    Chem Commun (Camb); 2013 Oct; 49(76):8522-4. PubMed ID: 23942760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An in vivo active 1,2,5-oxadiazole Pt(II) complex: A promising anticancer agent endowed with STAT3 inhibitory properties.
    Porta F; Facchetti G; Ferri N; Gelain A; Meneghetti F; Villa S; Barlocco D; Masciocchi D; Asai A; Miyoshi N; Marchianò S; Kwon BM; Jin Y; Gandin V; Marzano C; Rimoldi I
    Eur J Med Chem; 2017 May; 131():196-206. PubMed ID: 28324784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.